almirall sa (ALM:Continuous)
As of 11:38 AM 05/22/13 All times are local (Market data is delayed by at least 15 minutes).
Executive Profile*
Eduardo Javier Sanchiz YrazuChief Executive Officer, Member of Management Board, Chief Executive of Corporate Development & Finance and Executive Director, Almirall, S.A. |
| Age | Total Calculated Compensation | This person is connected to 11 board members in 1 different organizations across 1 different industries. See Board Relationships |
| -- | -- |
Background*
Mr. Eduardo Javier Sanchiz Yrazu serves as the Chief Executive of Corporate Development & Finance and Member of Management Board at Laboratorios Almirall SA and has been its Executive Director since January 1, 2005.
Corporate Headquarters*General Mitre, 151Barcelona, Catalonia 08022 Spain Phone: 34 93 291 30 00 Fax: 34 93 291 31 80 Board Members Memberships*2005-Present Chief Executive Officer, Member of Management Board, Chief Executive of Corporate Development & Finance and Executive Director
Education*There is no Education data available.Other Affiliations*There is no Company Affiliations data available. |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*There is no Total Compensation data available. |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| ALM:SM | €9.62 EUR | -0.04 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Rick E. Winningham | Chairman, Chief Executive Officer, Member of Stock Option Committee and Member of Science & Technology Advisory Committee Theravance Inc. | $868.4K |
| Peter M. Hecht Ph.D. | Co-Founder, Chief Executive Officer and Director Ironwood Pharmaceuticals, Inc. | $100.0K |
| Flemming Ornskov M.D., MBA, MPH | Chief Executive Officer, Head of Human Genetic Therapies and Director Shire plc | -- |
| Stephen A. Hill B.M. B.Ch. M.A. F.R.C.S. | Chief Executive Officer, President and Director Targacept, Inc. | $41.7K |
| Ryuji Ueno M.D., Ph.D., Ph.D. | Co-Founder, Chairman, Chief Executive Officer, Chief Scientific Officer and Member of Science & Technology Committee Sucampo Pharmaceuticals, Inc. | $589.0K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact ALMIRALL SA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
